Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2021-01, Vol.12, p.609508-609508
Main Authors: Vorobjeva, Nina V, Sud'ina, Galina F, Chernyak, Boris V
Format: Article
Language:English
Subjects:
COVID-19
mitochondria
NADPH oxidase
neutrophils
Pharmacology
pneumonia
reactive oxygen species
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-bc57f0e8cd125404a165d6de3988160c6cac140480f0d994a4960d3e78e8c3c33
cites cdi_FETCH-LOGICAL-c465t-bc57f0e8cd125404a165d6de3988160c6cac140480f0d994a4960d3e78e8c3c33
container_end_page 609508
container_issue
container_start_page 609508
container_title Frontiers in pharmacology
container_volume 12
creator Vorobjeva, Nina V
Sud'ina, Galina F
Chernyak, Boris V
description
doi_str_mv 10.3389/fphar.2021.609508
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_eddf79e15e2e43ea817a3dc27e173bb2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_eddf79e15e2e43ea817a3dc27e173bb2</doaj_id><sourcerecordid>2489597455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-bc57f0e8cd125404a165d6de3988160c6cac140480f0d994a4960d3e78e8c3c33</originalsourceid><addsrcrecordid>eNpVkl1vFCEUhonR2GbtD_DGcOnNrjDMB9yYbHb9mKRaE6u3hIUzMzQzMAJT43_wR8t2a9NyA3nPeZ9D4EXoNSUbxrh4182DCpuCFHRTE1ER_gyd07pma8Fp8fzR-QxdxHhD8mJCsLp8ic4Yq3jJKD9Hf7_Y5PXgnQlW4W0A_M0ncMmqEV-r0EOKuPMBpwHwHm5h9POUy9h3-Cv8xvuw9BFve2VdTFlZUvDzYEerceu6UU2TStY7bB3-nt1HvINl8i4Pa50eF2Ndj3dXP9v9mopX6EWnxggX9_sK_fj44Xr3eX159andbS_XuqyrtD7oqukIcG1oUZWkVLSuTG2ACc5pTXStlaZZ56QjRohSlaImhkHDs4dpxlaoPXGNVzdyDnZS4Y_0yso7wYdeqpCsHkGCMV0jgFZQQMlAcdooZnTRAG3Y4VBk1vsTa14OExidHyeo8Qn0acXZQfb-Vja84Sz_0Qq9vQcE_2uBmORko4ZxVA78EmVRclGJpqyq3EpPrTr4GAN0D2MokcdQyLtQyGMo5CkU2fPm8f0eHP8jwP4BPZ62AA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489597455</pqid></control><display><type>article</type><title>Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19</title><source>PubMed Central(OpenAccess)</source><creator>Vorobjeva, Nina V ; Sud'ina, Galina F ; Chernyak, Boris V</creator><creatorcontrib>Vorobjeva, Nina V ; Sud'ina, Galina F ; Chernyak, Boris V</creatorcontrib><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2021.609508</identifier><identifier>PMID: 33584318</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>COVID-19 ; mitochondria ; NADPH oxidase ; neutrophils ; Pharmacology ; pneumonia ; reactive oxygen species</subject><ispartof>Frontiers in pharmacology, 2021-01, Vol.12, p.609508-609508</ispartof><rights>Copyright © 2021 Vorobjeva, Sud'ina and Chernyak. 2021 Vorobjeva, Sud'ina and Chernyak</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-bc57f0e8cd125404a165d6de3988160c6cac140480f0d994a4960d3e78e8c3c33</citedby><cites>FETCH-LOGICAL-c465t-bc57f0e8cd125404a165d6de3988160c6cac140480f0d994a4960d3e78e8c3c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878366/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878366/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33584318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vorobjeva, Nina V</creatorcontrib><creatorcontrib>Sud'ina, Galina F</creatorcontrib><creatorcontrib>Chernyak, Boris V</creatorcontrib><title>Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19</title><title>Frontiers in pharmacology</title><addtitle>Front Pharmacol</addtitle><subject>COVID-19</subject><subject>mitochondria</subject><subject>NADPH oxidase</subject><subject>neutrophils</subject><subject>Pharmacology</subject><subject>pneumonia</subject><subject>reactive oxygen species</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkl1vFCEUhonR2GbtD_DGcOnNrjDMB9yYbHb9mKRaE6u3hIUzMzQzMAJT43_wR8t2a9NyA3nPeZ9D4EXoNSUbxrh4182DCpuCFHRTE1ER_gyd07pma8Fp8fzR-QxdxHhD8mJCsLp8ic4Yq3jJKD9Hf7_Y5PXgnQlW4W0A_M0ncMmqEV-r0EOKuPMBpwHwHm5h9POUy9h3-Cv8xvuw9BFve2VdTFlZUvDzYEerceu6UU2TStY7bB3-nt1HvINl8i4Pa50eF2Ndj3dXP9v9mopX6EWnxggX9_sK_fj44Xr3eX159andbS_XuqyrtD7oqukIcG1oUZWkVLSuTG2ACc5pTXStlaZZ56QjRohSlaImhkHDs4dpxlaoPXGNVzdyDnZS4Y_0yso7wYdeqpCsHkGCMV0jgFZQQMlAcdooZnTRAG3Y4VBk1vsTa14OExidHyeo8Qn0acXZQfb-Vja84Sz_0Qq9vQcE_2uBmORko4ZxVA78EmVRclGJpqyq3EpPrTr4GAN0D2MokcdQyLtQyGMo5CkU2fPm8f0eHP8jwP4BPZ62AA</recordid><startdate>20210129</startdate><enddate>20210129</enddate><creator>Vorobjeva, Nina V</creator><creator>Sud'ina, Galina F</creator><creator>Chernyak, Boris V</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210129</creationdate><title>Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19</title><author>Vorobjeva, Nina V ; Sud'ina, Galina F ; Chernyak, Boris V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-bc57f0e8cd125404a165d6de3988160c6cac140480f0d994a4960d3e78e8c3c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>COVID-19</topic><topic>mitochondria</topic><topic>NADPH oxidase</topic><topic>neutrophils</topic><topic>Pharmacology</topic><topic>pneumonia</topic><topic>reactive oxygen species</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vorobjeva, Nina V</creatorcontrib><creatorcontrib>Sud'ina, Galina F</creatorcontrib><creatorcontrib>Chernyak, Boris V</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vorobjeva, Nina V</au><au>Sud'ina, Galina F</au><au>Chernyak, Boris V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19</atitle><jtitle>Frontiers in pharmacology</jtitle><addtitle>Front Pharmacol</addtitle><date>2021-01-29</date><risdate>2021</risdate><volume>12</volume><spage>609508</spage><epage>609508</epage><pages>609508-609508</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>33584318</pmid><doi>10.3389/fphar.2021.609508</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2021-01, Vol.12, p.609508-609508
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_eddf79e15e2e43ea817a3dc27e173bb2
source PubMed Central(OpenAccess)
subjects COVID-19
mitochondria
NADPH oxidase
neutrophils
Pharmacology
pneumonia
reactive oxygen species
title Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A23%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondria%20Are%20Potential%20Targets%20for%20the%20Development%20of%20New%20Drugs%20Against%20Neutrophilic%20Inflammation%20in%20Severe%20Pneumonia%20Including%20COVID-19&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Vorobjeva,%20Nina%20V&rft.date=2021-01-29&rft.volume=12&rft.spage=609508&rft.epage=609508&rft.pages=609508-609508&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2021.609508&rft_dat=%3Cproquest_doaj_%3E2489597455%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-bc57f0e8cd125404a165d6de3988160c6cac140480f0d994a4960d3e78e8c3c33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2489597455&rft_id=info:pmid/33584318&rfr_iscdi=true